Product Information
AZSTARYS 39.2 MG-7.8 MG CAP is a brand product labeled by Corium, LLC., priced at $14.4184 per EA under NDC 65038042999. Its NADAC has been published 229 times since May 18, 2022.
FDA first approved this application on May 7, 2021.
Strength
7.8; 39.2 mg/1; mg/1
Manufacturer
Corium, LLC.NDC
65038042999
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212994FDA Approved
5/7/2021
On Market Since
7/16/2021
Pharmacological Classes
Price Statistics
The NADAC for AZSTARYS 39.2 MG-7.8 MG CAP has been published 229 times since May 18, 2022, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.4184 per EA |
|---|---|
| All-time high | $14.4426 (May 13, 2026) |
| All-time low | $12.3756 (Feb 22, 2023) |
| 52-week high | $14.4426 |
| 52-week low | $13.8871 |
| Median price | $13.3855 |
| Average price | $13.3811 |
| Largest weekly change | +4.0% (Jul 12, 2023) |
| Weeks tracked | 229 |
| Tracking since | May 18, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Serdexmethylphenidate and Dexmethylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Corium, LLC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Serdexmethylphenidate and Dexmethylphenidate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZSTARYS 39.2 MG-7.8 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for AZSTARYS 39.2 MG-7.8 MG CAP, manufactured by Corium, LLC., is $14.4184 per EA (NDC 65038042999), effective Sep 30, 2026.
How has the price of AZSTARYS 39.2 MG-7.8 MG CAP changed over time?
Over the history we have for it, the NADAC for AZSTARYS 39.2 MG-7.8 MG CAP has risen 15.7%. It has been tracked across 229 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for AZSTARYS 39.2 MG-7.8 MG CAP?
Since May 18, 2022, the NADAC for AZSTARYS 39.2 MG-7.8 MG CAP has ranged from a low of $12.3756 (Feb 22, 2023) to a high of $14.4426 (May 13, 2026), with a median of $13.3855 per EA.
Are there cheaper alternatives to AZSTARYS 39.2 MG-7.8 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of AZSTARYS 39.2 MG-7.8 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZSTARYS 39.2 MG-7.8 MG CAP?
AZSTARYS 39.2 MG-7.8 MG CAP (NDC 65038042999) is labeled by Corium, LLC., and CMS classifies it as a brand product.